|
| Press Releases |
|
 |
|
| Friday, August 29, 2025 |
|
|
Fosun's Bold Innovation & Globalization Drive Valuation Upside |
| Fosun International (HKEX: 00656) announced its 2025 interim results, with total revenue reaching RMB87.28 billion, industrial operation profit amounting to RMB3.15 billion, and profit attributable to owners of the parent reaching RMB661.2 million. more info >> |
|
|
復星創新和全球化多點破局 估值打開想像空間 |
| 復星國際（HKEX: 00656）發佈2025年上半年業績，總收入達人民幣872.8億元，產業運營利潤達人民幣31.5億元，歸母淨利潤達人民幣6.6億元。 more info >> |
|
| Tuesday, April 1, 2025 |
|
|
Fosun's Stable Fundamentals Support its Clear Growth Path |
| Fosun International (HKEX: 0656), which is committed to advancing its core business-focused and business streamlining strategy, announced its 2024 annual results on 30 March. more info >> |
|
|
復星年度業績基本面穩健，未來增長路徑清晰 |
| 持續推進「瘦身健體，聚焦主業」的復星國際，3月30日公佈2024年全年業績。 more info >> |
|
| Monday, March 31, 2025 |
|
|
Fosun's Core Businesses Stay Firm Despite One-off Non-cash Loss |
| On 30 March, Fosun International (00656) announced its 2024 annual results, reporting a total revenue of RMB192.14 billion. The Group's four core subsidiaries - Yuyuan, Fosun Pharma, Fosun Insurance Portugal, and Fosun Tourism Group ("FTG") - generated a total revenue of RMB134.65 billion, accounting for 70.1% of the Group's total revenue. more info >> |
|
|
复星一次性非现金账面损失不影响业务稳健发展 |
| 3月30日，复星国际（00656）公布2024年度业绩，总收入达到人民币1921.4亿元，其中，四大核心子公司豫园股份、复星医药、复星葡萄牙保险和复星旅文，总收入达到人民币1346.5亿元，占集团总收入的比重达到70.1%。归属于母公司股东之亏损为人民币43.5亿元，主要是受累阿里巴巴集团低价回购菜鸟致股份账面值大减。 more info >> |
|
|
復星一次性非現金賬面損失不影響業務穩健發展 |
| 3月30日，復星國際（00656）公佈2024年度業績，總收入達到人民幣1921.4億元，其中，四大核心子公司豫園股份、復星醫藥、復星葡萄牙保險和復星旅文，總收入達到人民幣1346.5億元，佔集團總收入的比重達到70.1%。歸屬於母公司股東之虧損為人民幣43.5億元，主要是受累阿里巴巴集團低價回購菜鳥致股份賬面值大減。 more info >> |
|
| Friday, December 13, 2024 |
|
|
Fosun Bolsters Core Business with Two Key Asset Privatizations |
| On the evening of 10 December, Fosun Tourism Group (FTG) announced on the Hong Kong Stock Exchange its plan to repurchase shares at a price of HK$7.8 per share. This price represents a 111% premium over the closing price of the day before the last trading day. more info >> |
|
|
连续私有化两家核心企业 复星深化主业布局 |
| 12月10日晚间，复星旅文在港交所发布公告，宣布拟以每股7.8港元的价格回购股份。该价格较最后交易日前一天的收盘价溢价111%。本次私有化将复星旅文的整体估值提升至105亿港元。消息一出，引发广泛关注。 more info >> |
|
|
連續私有化兩家核心企業 復星深化主業佈局 |
| 12月10日晚間，復星旅文在港交所發佈公告，宣佈擬以每股7.8港元的價格回購股份。該價格較最後交易日前一天的收盤價溢價111%。本次私有化將復星旅文的整體估值提升至105億港元。消息一出，引發廣泛關注。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
国资护航+技术壁垒+优质保荐 华芢生物（02396.HK）PDGF管线直指18A赛道确定性价值
Dec 15, 2025 11:05 HKT/SGT
|
|
|
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
國資護航+技術壁壘+優質保薦 華芢生物（02396.HK）PDGF管線直指18A賽道確定性價值
Dec 15, 2025 09:28 HKT/SGT
|
|
|
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Dec 15, 2025 8:30 JST
|
|
|
韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ
Dec 13, 2025 13:00: JST
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
|
|
|
京東工業登陸港交所：業績與品牌雙賦能 長期成長潛力可期
Dec 12, 2025 17:05 HKT/SGT
|
|
|
京东工业登陆港交所：业绩与品牌双赋能 长期成长潜力可期
Dec 12, 2025 17:04 HKT/SGT
|
|
|
京東工業配售結果出爐：MRO龍頭實力領跑 全鏈條數智化解決方案釋放長期價值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
京东工业配售结果出炉：MRO龙头实力领跑 全链条数智化解决方案释放长期价值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
全鏈條服務+業績高增長彰顯實力 京東工業港交所上市釋放長期價值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
全链条服务+业绩高增长彰显实力 京东工业港交所上市释放长期价值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
首隻山水實景表演概念股 印象大紅袍啟動香港公開募股
Dec 12, 2025 15:01 HKT/SGT
|
|
|
首只山水实景表演概念股 印象大红袍启动香港公开募股
Dec 12, 2025 15:00 HKT/SGT
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
